A really inspiring development in the digital therapeutics sphere with the FDA approving a video based game as a prescription treatment for ADHD. It will be really interesting to see, especially in a post-Covid world, how tech solutions are able to help us in more diverse ways - and how both big tech and more traditional healthcare companies will adjust and potentially collaborate.
| less than a minute read
FDA approve video game as a clinical treatment
Get in touch
Get in touch
Akili today announced that the U.S. Food and Drug Administration (FDA) has granted clearance for EndeavorRxTM (AKL-T01) as a prescription treatment for children with attention deficit hyperactivity disorder (ADHD). Delivered through a captivating video game experience, EndeavorRx is indicated to improve attention function as measured by computer-based testing in children ages 8-12 years old with primarily inattentive or combined-type ADHD, who have a demonstrated attention issue.
Get in touch
Get in touch
/Passle/596df0e43d947619ec025f26/MediaLibrary/Images/2024-10-08-10-50-28-575-67050e74c71f57809f6d0411.jpg)
Introduction Over the next 2 months, the DLA Piper Life Sciences Blog: Cortex will feature a series of articles providing an insight into...
/Passle/596df0e43d947619ec025f26/MediaLibrary/Images/2024-11-05-09-46-46-710-6729e986fa0caa16109ca90f.jpg)
/Passle/596df0e43d947619ec025f26/MediaLibrary/Document/2024-11-05-09-42-20-904-A25696_Life_Sciences_Brochure_OctoberEN_Brochure_V2_FINAL_thumbnail_1.png)
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2024-10-31-16-30-14-487-6723b096063041cc69f3284b.jpg)
/Passle/596df0e43d947619ec025f26/MediaLibrary/Images/2024-10-31-10-07-50-942-672356f6f951b3897d445fb3.jpg)
